Short answer
VIEMED HEALTHCARE, INC. (VMD) filed its Q3 2025 10-Q quarterly report on Nov 5, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $72M (up 24.0% year over year) with net income of $4M.
Q3 2025 key financials · XBRL
- Revenue
- $72M
- +24.0% YoY · +14.0% QoQ
- Net income
- $4M
- −9.4% YoY · +11.3% QoQ
- Operating margin
- 7.8%
- Gross margin
- 57.5%
- EPS (diluted)
- $0.09
- +0.0% YoY · +12.5% QoQ
Source: XBRL data from the VIEMED HEALTHCARE, INC. (VMD) Q3 2025 10-Q on SEC EDGAR. USD.
VIEMED HEALTHCARE, INC. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New reimbursement risk triggered by CMS’s June 9, 2025 NCD establishing NIPPV medical-necessity criteria for COPD-related chronic respiratory failure
- Most material update: Medicare policy may affect commercial payors, including Medicare Advantage plans, broadening potential reimbursement impact
- Regulatory risk: Medicare and third-party payor coverage reductions could materially impair patient access, utilization, and results
- Operational risk: raw-material shortages, supplier lead times, and transportation costs could delay essential equipment acquisition
- Financial risk: tariffs and currency movements involving the Canadian dollar and Chinese yuan could increase costs and reduce gross margins
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other VIEMED HEALTHCARE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.